The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies

BACKGROUND: Alzheimer’s disease (AD)-related pathology is frequently found in patients with dementia with Lewy bodies (DLB). However, it is unknown how amyloid-β and tau-related pathologies influence neurodegeneration in DLB. Understanding the mechanisms underlying brain atrophy in DLB can improve o...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelnour, Carla, Ferreira, Daniel, Oppedal, Ketil, Cavallin, Lena, Bousiges, Olivier, Wahlund, Lars Olof, Hort, Jakub, Nedelska, Zuzana, Padovani, Alessandro, Pilotto, Andrea, Bonanni, Laura, Kramberger, Milica G., Boada, Mercè, Westman, Eric, Pagonabarraga, Javier, Kulisevsky, Jaime, Blanc, Frédéric, Aarsland, Dag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363702/
https://www.ncbi.nlm.nih.gov/pubmed/32674011
http://dx.doi.org/10.1016/j.nicl.2020.102333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363702/
https://www.ncbi.nlm.nih.gov/pubmed/32674011
http://dx.doi.org/10.1016/j.nicl.2020.102333

Ejemplares similares